obhud.com
Open in
urlscan Pro
2606:4700:3032::6815:32e0
Public Scan
Submitted URL: https://obhud.com/
Effective URL: https://obhud.com/pc
Submission: On January 29 via api from US — Scanned from US
Effective URL: https://obhud.com/pc
Submission: On January 29 via api from US — Scanned from US
Form analysis
2 forms found in the DOMGET /pc/search
<form role="search" method="get" class="pc-searchform" action="/pc/search">
<div class="pc-searchform-inner">
<input type="text" class="search-input" placeholder="Type and hit enter..." name="keyword"> <i class="penciicon-magnifiying-glass"></i>
<button type="submit" class="searchsubmit">Search</button>
</div>
</form>
GET /pc/search
<form role="search" method="get" class="pc-searchform" action="/pc/search">
<div class="pc-searchform-inner">
<input type="text" class="search-input" placeholder="Type and hit enter..." name="keyword">
<i class="penciicon-magnifiying-glass"></i>
<button type="submit" class="searchsubmit">Search</button>
</div>
</form>
Text Content
Search Search * Home * Medical * Disease * Healthy * Apparatus * Hospital Advertisement LATEST UPDATE Medical NEW RESEARCH: CRACKING THE TARGETED DRUG RESISTANCE PUZZLE AND ELIMINATING CANCER CELLS BEFORE THEY EVOLVE! Jan 29, 2024 Disease DON'T TREAT ALLERGIC RHINITIS AS A COLD Jan 29, 2024 Healthy WHAT TO EAT TO CLEANSE AND MOISTEN THE LUNGS Jan 29, 2024 Apparatus SPECIALISING IN RNA 3D STRUCTURE PREDICTION, ATOMIC AI WANTS TO LAUNCH AN RNA VERSION OF ALPHAFOLD TO ACCELERATE DRUG DISCOVERY! Jan 29, 2024 Hospital MOFFITT CANCER CENTER & RESEARCH INSTITUTE Jan 29, 2024 New Research: Cracking The Targeted Drug Resistance Puzzle And Eliminating Cancer Cells Before They Evolve! Jan 29, 2024 There Is No Cure For Alzheimer's Disease And Death Usually Occurs Within Ten Years Of Diagnosis, So The Best Option Now Is To Prevent It Early. Jan 10, 2024 What To Eat To Cleanse And Moisten The Lungs Jan 29, 2024 MEDICAL SEE LATEST CANCER CELLS ARE SO CUNNING THEY USE 'SELF-EVOLUTION' TO RESIST TREATMENT! NEW RESEARCH HAS FOUND THE ANSWER Jul 09, 2023 WHY IS ASTRAZENECA WILLING TO SPEND A WHOPPING $12.1 BILLION? Dec 31, 2023 New Study: Nmn Supplementation Activates Longevity Proteins To Reduce Stem Cell Senescence And Restore Mitochondrial Function Oct 09, 2023 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Dec 26, 2023 Good News, Orphan Drug Status Granted By The FDA For Ezurpimtrostat, a Cutting Edge Drug For Liver Cancer! Dec 29, 2023 Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Aug 08, 2023 DISEASE SEE LATEST CAN A LARGE GLASS OF COKE A DAY LEAD TO OSTEOPOROSIS? Dec 17, 2023 We don't yet know exactly how much Coke and how long you have to drink it before it causes osteoporosis Do I Have Breast Cancer? Jan 12, 2024 What Are The Side Effects Of Radiotherapy For Prostate Cancer? What Should Patients With Prostate Cancer Be Aware Of? Nov 19, 2023 Coronary Heart Disease, How To Use The Right Medication? Jan 15, 2024 HEALTHY SEE LATEST WHAT FOODS SHOULD OLDER PEOPLE NOT EAT AFTER A STROKE Dec 30, 2023 DIETARY CONTRAINDICATIONS FOR WOMEN DURING PREGNANCY PREPARATION Aug 05, 2023 WHAT ARE THE DANGERS OF ANAEMIA DURING PREGNANCY? Aug 06, 2023 APPARATUS SEE LATEST AIRWAY ANNOUNCES FIRST PATIENT TO RECEIVE DOSE IN BPD TRIAL Nov 02, 2023 Biopharmaceutical company Airway has announced that the first patient will be administered AT-100 (rhSP-D) in a phase 1b randomised trial to prevent the risk of bronchopulmonary dysplasia (BPD) in very preterm infants. The novel prophylactic AT-100 reduces the incidence and severity of the severe respiratory disease BPD and may improve the prognosis of very preterm infants. ACS MED. CHEM. LETT.| PROTAC-TARGETED JAK2 PROTEIN KINASE: A NEW APPROACH TO CANCER THERAPY Nov 14, 2023 GOOD CLINICAL DATA FOR SRF388, AN INNOVATIVE LUNG CANCER DRUG, WITH PATIENTS STABLE FOR Jan 08, 2024 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For Jan 08, 2024 Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Dec 04, 2023 FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit! Dec 24, 2023 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Dec 01, 2023 Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved! Jul 05, 2023 HOSPITAL SEE LATEST City of Hope NationalMedical Center Oct 04, 2023 Cancer Institute Hospital of JFCR Dec 25, 2023 Royal Marsden Cancer Centre Dec 29, 2023 Shizuoka National Epilepsy Centre, Japan Jan 05, 2024 Medipolis Proton Therapy Centre, Japan Jan 04, 2024 Dana-Farber Cancer Research, Teaching Affiliate, Harvard Medical School Jan 13, 2024 UNIVERSITY HOSPITAL HEIDELBERG, GERMANY Oct 16, 2023 RECENT ARTICLES NEW RESEARCH: CRACKING THE TARGETED DRUG RESISTANCE PUZZLE AND ELIMINATING CANCER CELLS BEFORE THEY EVOLVE! Jan 29, 2024 Don't treat allergic rhinitis as a cold Jan 29, 2024 Specialising in RNA 3D structure prediction, Atomic AI wants to launch an RNA version of AlphaFold to accelerate drug discovery! Jan 29, 2024 Moffitt Cancer Center & Research Institute Jan 29, 2024 User Agreement | Privacy Policy Copyright © 2024 obhud.com. All rights reserved.